EP0341303A4 - Monoclonal antibody against the rgd-directed adhesion receptor of endothelial cells. - Google Patents
Monoclonal antibody against the rgd-directed adhesion receptor of endothelial cells.Info
- Publication number
- EP0341303A4 EP0341303A4 EP19890900512 EP89900512A EP0341303A4 EP 0341303 A4 EP0341303 A4 EP 0341303A4 EP 19890900512 EP19890900512 EP 19890900512 EP 89900512 A EP89900512 A EP 89900512A EP 0341303 A4 EP0341303 A4 EP 0341303A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- rgd
- monoclonal antibody
- endothelial cells
- antibody against
- adhesion receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12304587A | 1987-11-19 | 1987-11-19 | |
US123045 | 1987-11-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0341303A1 EP0341303A1 (en) | 1989-11-15 |
EP0341303A4 true EP0341303A4 (en) | 1990-06-27 |
Family
ID=22406412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19890900512 Withdrawn EP0341303A4 (en) | 1987-11-19 | 1988-11-17 | Monoclonal antibody against the rgd-directed adhesion receptor of endothelial cells. |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0341303A4 (en) |
JP (1) | JPH02502156A (en) |
AU (1) | AU2807189A (en) |
FI (1) | FI893475A (en) |
WO (1) | WO1989005155A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6521594B1 (en) | 1990-04-06 | 2003-02-18 | La Jolla Cancer Research Foundation | Method and composition for treating thrombosis |
US5612311A (en) | 1990-04-06 | 1997-03-18 | La Jolla Cancer Research Foundation | Method and composition for treating thrombosis |
US5780303A (en) * | 1990-04-06 | 1998-07-14 | La Jolla Cancer Research Foundation | Method and composition for treating thrombosis |
US5672585A (en) * | 1990-04-06 | 1997-09-30 | La Jolla Cancer Research Foundation | Method and composition for treating thrombosis |
DE69322860T2 (en) * | 1992-04-03 | 1999-07-01 | Genentech Inc | ANTIBODIES AGAINST ALPHA V BETA 3 INTEGRIN |
JP3490443B2 (en) † | 1992-10-29 | 2004-01-26 | ジ・オーストラリアン・ナショナル・ユニバーシティ | Anti-angiogenic antibody |
US5753230A (en) * | 1994-03-18 | 1998-05-19 | The Scripps Research Institute | Methods and compositions useful for inhibition of angiogenesis |
US6056958A (en) * | 1994-12-09 | 2000-05-02 | Dupont Pharmaceuticals | Method of treatment of arterial and venous thromboembolic disorders |
RU2195312C2 (en) | 1996-05-31 | 2002-12-27 | Дзе Скриппс Рисерч Инститьют | TECHNIQUES AND COMPOSITIONS USED TO INHIBIT αvβ5-CAUSED ANGIOGENESIS |
ES2234099T3 (en) | 1997-03-12 | 2005-06-16 | Smithkline Beecham Corporation | ANTI-ALFA BETA 3 HUMANIZED MONOCLANAL ANTIBODIES 3. |
DK0973550T3 (en) * | 1997-04-11 | 2003-02-10 | Searle & Co | Antagonistic anti-AVB3 integrin antibodies |
US6193968B1 (en) | 1997-04-11 | 2001-02-27 | The Burnham Institute | Methods for using anti-αvβ3 integrin antibody |
US6160099A (en) * | 1998-11-24 | 2000-12-12 | Jonak; Zdenka Ludmila | Anti-human αv β3 and αv β5 antibodies |
AU2006261920A1 (en) | 2005-06-23 | 2007-01-04 | Medimmune, Llc | Antibody formulations having optimized aggregation and fragmentation profiles |
EP2467401B1 (en) | 2009-08-19 | 2017-01-18 | Merck Patent GmbH | Antibodies for the detection of integrin complexes in ffpe material |
-
1988
- 1988-11-17 EP EP19890900512 patent/EP0341303A4/en not_active Withdrawn
- 1988-11-17 AU AU28071/89A patent/AU2807189A/en not_active Abandoned
- 1988-11-17 WO PCT/US1988/004118 patent/WO1989005155A1/en not_active Application Discontinuation
- 1988-11-17 JP JP1500220A patent/JPH02502156A/en active Pending
-
1989
- 1989-07-18 FI FI893475A patent/FI893475A/en not_active IP Right Cessation
Non-Patent Citations (2)
Title |
---|
Proc. Natl. Acad. Sci. USA, Vol. 84, September 1987, pages 6471-6475; D.A. CHERESH: "Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor", the whole article. * |
See also references of WO8905155A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO1989005155A1 (en) | 1989-06-15 |
AU2807189A (en) | 1989-07-05 |
FI893475A0 (en) | 1989-07-18 |
FI893475A (en) | 1989-07-18 |
JPH02502156A (en) | 1990-07-19 |
EP0341303A1 (en) | 1989-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0404912A4 (en) | Monoclonal antibodies reactive with defined regions of the t cell antigen receptor | |
IL87535A0 (en) | Cell lines and monoclonal antibodies | |
EP0341303A4 (en) | Monoclonal antibody against the rgd-directed adhesion receptor of endothelial cells. | |
IL90017A0 (en) | Monoclonal antibodies | |
ZA898777B (en) | Monoclonal antibodies | |
EP0285511A3 (en) | Monoclonal antibodies and their uses | |
IL92232A0 (en) | Anti-fucosylceramide monoclonal antibody | |
EP0759943A4 (en) | Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof | |
ES8606662A1 (en) | Monoclonal antibody. | |
EP0363712A3 (en) | Hybrid monoclonal antibodies, their production and use | |
AU3829189A (en) | Detecting antigens or antibodies | |
ZA89258B (en) | Monoclonal antibodies | |
EP0289252A3 (en) | Anti-t cell receptor, y-chain monoclonal antibody | |
GB8820036D0 (en) | Monoclonal antibodies | |
AU618720B2 (en) | Monoclonal antibodies | |
GB8816366D0 (en) | Hybridoma cells & monoclonal antibodies | |
EP0336441A3 (en) | Anti-cpbii monoclonal antibody | |
IE871067L (en) | Anti-rhesus d monoclonal antibody. | |
ZA883563B (en) | Monoclonal antibody specific for the adhesion function domain of a phagocyte cell surface protein | |
AU612766C (en) | Monoclonal antibodies | |
GB8820035D0 (en) | Monoclonal antibodies | |
ZA892882B (en) | Monoclonal antibodies | |
GB8812962D0 (en) | Monoclonal antibodies | |
GB8812963D0 (en) | Monoclonal antibodies | |
GB8619905D0 (en) | Monoclonal antibody |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19890707 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19900627 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 19900915 |